Use Caution/Monitor. Coadministration of mild CYP3A4 inhibitors with midazolam intranasal may cause higher midazolam systemic exposure, which may prolong sedation. Monitor Closely (2)dronedarone will increase the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)methylprednisolone will decrease the level or effect of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)methylprednisolone, furosemide. Monitor Closely (1)encorafenib, methylprednisolone. Serious - Use Alternative (1)methylprednisolone, macimorelin. Monitor Closely (1)methylprednisolone and moxifloxacin both increase Other (see comment). Monitor Closely (1)methylprednisolone will increase the level or effect of atogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)methylprednisolone will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (2)methylprednisolone will decrease the level or effect of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. John's wort, some drugs used to treat seizures (such as phenytoin, phenobarbital), among others.This medication may interfere with certain laboratory tests (such as skin tests), possibly causing false test results. Fexinidazole inhibits CYP3A4. Coadministration may increase risk for adverse effects of CYP3A4 substrates. Monitor Closely (1)aspirin rectal, methylprednisolone. Avoid or Use Alternate Drug. Corticosteroids may diminish therapeutic effects of vaccines and increase risk of adverse effects (increased risk of infection). Minor (1)methylprednisolone will decrease the level or effect of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Serious - Use Alternative (1)methylprednisolone decreases effects of travelers diarrhea and cholera vaccine inactivated by pharmacodynamic antagonism.

Depo provera progesterone

Serious - Use Alternative (1)methylprednisolone decreases effects of human papillomavirus vaccine, nonavalent by pharmacodynamic antagonism. A higher dose of corticosteroids may be required for desired clinical effect. Monitor Closely (1)itraconazole will increase the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)topiramate will decrease the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Your dose may need to be gradually decreased.If you suddenly stop using this medication, you may have withdrawal symptoms (such as weakness, weight loss, nausea, muscle pain, headache, tiredness, dizziness). Use Caution/Monitor.Serious - Use Alternative (1)clarithromycin will increase the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)methylprednisolone will decrease the level or effect of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If not feasible, vögele umstandsmode avoid use of abametapir. Serious - Use Alternative (1)methylprednisolone decreases effects of influenza virus vaccine quadrivalent, intranasal by pharmacodynamic antagonism. Minor/Significance Unknown. methylprednisolone decreases effects of saxagliptin by pharmacodynamic antagonism. DHEA, herbal will increase the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)methylprednisolone and levofloxacin both increase Other (see comment). Serious - Use Alternative (1)methylprednisolone decreases effects of typhoid polysaccharide vaccine by pharmacodynamic antagonism. Minor (1)methylprednisolone decreases levels of calcium chloride by increasing elimination. Monitor Closely (1)methylprednisolone increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. GI absorption. Applies only to oral form of both agents.

Medrol dosepak

Minor (1)methylprednisolone will decrease the level or effect of clomipramine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Methylprednisolone is available under the following different brand names: Medrol, Medrol Dosepak, DepoMedrol, and SoluMedrol. Monitor Closely (1)secobarbital will decrease the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Methylprednisolone has serious/ interactions with at least 75 different drugs. Tell your doctor right away if you have symptoms of high blood sugar such as increased thirst/urination. Monitor Closely (1)pancuronium, methylprednisolone. Comment: Coadministration of corticosteroids and neuromuscular blockers may increase risk of developing acute myopathy. Use Caution/Monitor. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors. Minor (1)testosterone topical, methylprednisolone. This information aim is educational only and is not devoted for medical recommendations, diagnosis or treatment. Use Caution/Monitor. Increased risk of GI ulceration.Minor (1)methylprednisolone decreases levels of sulfasalazine by increasing renal clearance. Minor (1)methylprednisolone decreases effects of nateglinide by pharmacodynamic antagonism. CYP3A4 metabolism. Use Caution/Monitor.amiodarone will increase the level or effect of methylprednisolone by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. Increased risk of GI ulceration.Minor (1)methylprednisolone decreases levels of salicylates (non-asa) by increasing renal clearance. Serious - Use Alternative (1)methylprednisolone decreases effects of influenza virus vaccine quadrivalent, adjuvanted by pharmacodynamic antagonism. Applies only to oral form of both agents.

Steroid medrol

Use Caution/Monitor.Serious - Use Alternative (1)carbamazepine will decrease the level or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)methylprednisolone decreases effects of vildagliptin by pharmacodynamic antagonism. Allow sufficient washout time of drugs affecting GH release before administering macimorelin. Monitor Closely (1)levoketoconazole will increase the level or effect of methylprednisolone by P-glycoprotein (MDR1) efflux transporter. Monitor blood glucose levels carefully. Evaluate for loss of therapeutic effect if medication must be coadministered. Use Caution/Monitor. amiodarone will increase the level or effect of methylprednisolone by P-glycoprotein (MDR1) efflux transporter. Minor (1)methylprednisolone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)tolmetin, methylprednisolone. Monitor Closely (1)cisatracurium, sertralin 50 mg gewichtszunahme methylprednisolone. Voxelotor increases systemic exposure of sensitive CYP3A4 substrates. Monitor Closely (2)methylprednisolone will decrease the level or effect of amiodarone by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Depo provera depression

If any of these effects last or get worse, tell your doctor or pharmacist promptly.Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Do not start, stop, or change the dosage of this medicine or any medicine before getting further information from your doctor, healthcare provider, or pharmacist first.